Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

My Oncologist Says I've 'Graduated' from Cancer

April 8th 2024, 5:00pm

Article

After five years of being cancer-free, my oncologist said I'm graduated and can live my life freely.

Moderate Multivitamin Use Associated With Lower CRC Mortality

March 19th 2024, 3:00pm

Article

Moderate multivitamin use was associated with a decreased risk of death in patients with colorectal cancer, though more research is needed, an expert said.

How I Navigate the Lynch Syndrome Labyrinth

March 11th 2024, 5:00pm

Article

Although many hate drinking the prep for colonoscopies, I view it as a privilege.

FDA to Speed Up Review of Krazati Combo for Metastatic CRC

February 20th 2024, 10:00pm

Article

The Food and Drug Administration granted a priority review to Krazati plus Erbitux for KRAS G12C-mutant locally advanced or metastatic colorectal cancer.

It’s Time to Let Go of My Relationship With Cancer

February 19th 2024, 6:00pm

Article

I recently said goodbye to my oncologist of five years now that I have no evidence of colorectal cancer; it's time to let go.

Courage Helped Me Become Cancer-Free

February 16th 2024, 6:00pm

Article

Even though conquering cancer scared me, I knew being courageous would help me with the fight.

The Road Ahead After Cancer

January 26th 2024, 6:00pm

Article

My wife's simple sentence to me ended up saving my life from colorectal cancer.

Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival

January 23rd 2024, 10:00pm

Article

Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.

Cancer in Bloodstream May Predict CRC Outcomes

January 23rd 2024, 2:00pm

Article

Circulating tumor DNA-based minimal residual disease lent insight into which patients with stage 2/3 colorectal cancer may be at higher risk for recurrence and which could benefit from postsurgical chemotherapy.

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC

January 22nd 2024, 8:00pm

Article

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.